An interview with Professor Seppo Ylä-Herttuala from the A. I. Virtanen Institute for Molecular Sciences at the University of Eastern Finland.
Entirely novel vaccines, developed at record speed, have been employed to mitigate the coronavirus pandemic. The technology these vaccines are based on has however been investigated for over 20 years, and it has been successfully used in several patient studies in e.g. oncology.